Market Overview

BMO Upgrades Mondelez To Outperform; Notes 'Clear' Growth Trajectory

Share:
Related
Watch These 5 Huge Put Purchases In Wednesday Trade
Watch These 5 Huge Call Purchases In Tuesday Trade
Big 20% Pullback: Buy The World Renowned Hershey Company? (Seeking Alpha)

In a report published Friday, BMO Capital Markets analyst Kenneth B. Zaslow upgraded the rating on Mondelez International Inc (NASDAQ: MDLZ) from Market Perform to Outperform, while raising the price target from $42 to $47, despite the company facing a challenging operating environment.

Analyst Kenneth B. Zaslow believes that Mondelez is now "a compelling investment opportunity." The company's long-term OI margins may exceed 18 percent and the path to achieving this has become clearer. Zaslow said that 2015 could mark the inflection point in the company's sales growth.

In the report BMO Capital Markets noted, "First, we believe MDLZ will drive margins by accelerating plant closings within its legacy network, implementing new “advantaged lines” across geographies, increasing overhead reductions, and expanding zero-based budgeting across geographies (e.g., emerging markets)."

Second, Zaslow expects the company's sales growth to continue to accelerate "for the next several years" reflecting:

  • New management in emerging markets
  • Optionality for the recovery of emerging markets
  • White space opportunities, particularly in emerging markets
  • Expansion of high-growth product platforms
  • Competitors’ pricing following Mondelez's recent actions

Third, along with a shift in focus toward margin expansion, the company continues to focus on "unleashing shareholder value," Zaslow said. This could be done via:

  • Returning cash to shareholders from non-core asset sales and operating cash flow
  • Tactical acquisitions that provide needed capabilities
  • Ongoing portfolio refinement

The EPS estimate for 2016 has been raised from $2.02 to $2.03.

Latest Ratings for MDLZ

DateFirmActionFromTo
Nov 2016Deutsche BankAssumesHold
Sep 2016JP MorganAssumesOverweight
Jul 2016Societe GeneraleDowngradesBuyHold

View More Analyst Ratings for MDLZ
View the Latest Analyst Ratings

Posted-In: BMO Capital MarketsAnalyst Color Upgrades Price Target Analyst Ratings

 

Related Articles (MDLZ)

View Comments and Join the Discussion!